Dr. Ryan Goldstein, MD
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Years since graduation
- 12
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 313
Licensed in Texas since 2018, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
TX license R7463 (first issued 2018; active) -
Internal Medicine Physician
TX license R7463 (first issued 2018; active) - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- North Austin Medical Center Austin, TX
Medical groups
- The Austin Diagnostic Clinic PLLC (86 clinicians)
- Gold Diagnostics Corp (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 313
- Services billed
- 1,717
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | 100 | 34 |
| Established patient office or other outpatient visit, 30-39 minutes | 85 | 69 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 78 | 78 |
| Biopsy of large bowel using a flexible endoscope | 78 | 78 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 57 | 48 |
| Established patient office or other outpatient visit, 20-29 minutes | 23 | 21 |
| Established patient office or other outpatient visit, 10-19 minutes | 19 | 13 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 19 | 19 |
| New patient office or other outpatient visit, 45-59 minutes | 17 | 17 |
| Removal of large bowel tissue using a flexible endoscope | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Pantoprazole Sodium Other prescribers in Austin, TX | 273 |
| Sod Sulf-Potass Sulf-Mag Sulf (sodium, potassium,mag sulfates) Other prescribers in Austin, TX | 30 |
| Famotidine Other prescribers in Austin, TX | 23 |
| Omeprazole Other prescribers in Austin, TX | 20 |
| Dexlansoprazole Dr (dexlansoprazole) Other prescribers in Austin, TX | 17 |
| Metronidazole Other prescribers in Austin, TX | 15 |
| Xifaxan (rifaximin) Other prescribers in Austin, TX | 15 |
| Peg 3350-Electrolyte (sodium chloride/nahco3/kcl/peg) | 13 |
| Sucralfate Other prescribers in Austin, TX | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 5 payments worth $98.66 in total to this clinician.
| Genzyme Corporation | $25.43 |
|---|---|
| AbbVie Inc. | $22.77 |
| Celltrion USA Inc. | $17.67 |
| Pfizer Inc. | $16.86 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.93 |
| Food and Beverage | $82.73 |
|---|---|
| Education | $15.93 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. Mar 10, 2025 | Education in-kind | $15.93 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.